Results of Reinduction Therapy with Paclitaxel and Carboplatin in Recurrent Epithelial Ovarian Cancer
- 31 October 2001
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 83 (1), 128-134
- https://doi.org/10.1006/gyno.2001.6364
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Exploratory Phase III Study of Paclitaxel and Cisplatin Versus Paclitaxel and Carboplatin in Advanced Ovarian CancerJournal of Clinical Oncology, 2000
- Advances in ovarian cancer chemotherapyCurrent Opinion in Oncology, 2000
- Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: An investigator-originated compassionate-use experienceAnnals of Oncology, 1999
- Factors Predictive of Survival after First Relapse or Progression in Advanced Epithelial Ovarian Carcinoma: A Prediction Tree Analysis-Derived Model with Test and Validation GroupsGynecologic Oncology, 1998
- “Recurrence within 6 Months of Platinum Therapy”: An Adequate Definition of “Platinum-Refractory” Ovarian Cancer?Gynecologic Oncology, 1998
- Second-line therapy with paclitaxel and carboplatin for recurrent disease following first-line therapy with paclitaxel and platinum in ovarian or peritoneal carcinoma.Journal of Clinical Oncology, 1998
- Response to Salvage Treatment in Recurrent Ovarian Cancer Treated Initially with Paclitaxel and Platinum-Based Combination RegimensGynecologic Oncology, 1998
- Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent Epithelial Ovarian CancerGynecologic Oncology, 1996
- Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group studyAnnals of Oncology, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996